Glenmark receives USFDA nod for Baddi plant

Glenmark Pharmaceuticals has received US Food & Drug Administration approval for its Baddi plant in Himachal Pradesh, which makes semi-solids (ointments and creams). The plant recently received GMP approval from MHRA of UK and from TPD of Canada.



The approval will enable Glenmark to enter the niche segment of semi-solid dosages in most of the regulated markets of the world. It envisages the launch of a basket of products in skin care treatment in the US and in EU markets.

Msg By Mr Saty